⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471432 | 0.83 | NPSR1 (0.35) | — | |
| SCHEMBL2439293 | 0.82 | CA12 (0.35) | — | |
| SCHEMBL2470745 | 0.81 | SIGMAR1 (0.36) | — | |
| SCHEMBL11622085 | 0.79 | PAOX (0.36) | — | |
| SCHEMBL7379222 | 0.79 | PAOX (0.36) | — | |
| SCHEMBL7673852 | 0.76 | CA12 (0.38) | — | |
| SCHEMBL2385651 | 0.74 | — | — | |
| SCHEMBL10769544 | 0.74 | KDM4E (0.34) | — | |
| SCHEMBL10350737 | 0.71 | — | — | |
| SCHEMBL10615158 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140309192-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC, | 2014-10-16 | — | — | US | claimed |
| EP-2776407-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| EP-2054411-B1 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORP (KR) | 2014-08-20 | — | — | EP | claimed |
| WO-2013070657-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-5760011-A | USEFUL AGAINST BACTERIAL AND MYCOPLASMIC PATHOGENS | PFIZER INC. (US) | 1998-06-02 | — | — | US | claimed |
| EP-0649430-B1 | DERIVATIVES OF 16-MEMBERED RING ANTIBIOTIC MACROLIDES | PFIZER (US) | 1997-12-17 | — | — | EP | claimed |
| US-5677287-A | TREATS MYCOPLASMIC INFECTIONS | PFIZER INC. (US) | 1997-10-14 | — | — | US | claimed |
| EP-0333174-B1 | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-05-08 | — | — | EP | claimed |
| EP-0708770-A1 | AMIDE DERIVATIVES OF 16-MEMBERED RING ANTIBIOTIC MACROLIDES | PFIZER (US) | 1996-05-01 | — | — | EP | claimed |
| WO-1996009312-A1 | ANTIBIOTIC MACROLIDES | PFIZER INC. (US) | 1996-03-28 | — | — | WO | claimed |
| EP-0649430-A1 | DERIVATIVES OF 16-MEMBERED RING ANTIBIOTIC MACROLIDES | PFIZER INC. (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1995002594-A1 | AMIDE DERIVATIVES OF 16-MEMBERED RING ANTIBIOTIC MACROLIDES | PFIZER INC. (US) | 1995-01-26 | — | — | WO | claimed |
| WO-1994021657-A1 | ANTIBACTERIAL 16-MEMBERED RING MACROLIDES CONTAINING OLEFINS AT C-20 | PFIZER INC. (US) | 1994-09-29 | — | — | WO | claimed |
| CN-1083068-A | The derivative of the macrolide of 16 membered ring antibiotics | PFIZER (US) | 1994-03-02 | — | — | CN | claimed |
| WO-1994002496-A1 | DERIVATIVES OF 16-MEMBERED RING ANTIBIOTIC MACROLIDES | PFIZER INC. (US) | 1994-02-03 | — | — | WO | claimed |
| US-5187156-A | D-Tryptophan- and Phenylalanine-containing tripeptides as tachykinin antagonists; asthma | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | claimed |
| EP-0333174-A2 | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-20 | — | — | EP | claimed |